Hôpital Saint-Louis — Paris

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Hôpital Saint-Louis, compiled from the ClinicalTrials.gov public registry.

628

Registered studies

210

Active

114

Recruiting now

301

Completed

Stopped or withdrawn

Most-studied conditions

Type 1 Diabetes · Human Immunodeficiency Virus Type 1 (HIV-1) Infection · Low-risk Myelodysplastic Syndromes · HER2- Negative Breast Cancer

Recently updated registry entries

NCT06422143 — Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in… (Recruiting)
NCT06670222 — Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS) (Recruiting)
NCT06056297 — A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.